Fortitude Family Office’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.79K Sell
82
-65
-44% -$3.51K ﹤0.01% 1012
2026
Q1
$7.68K Sell
147
-110
-43% -$6.6K ﹤0.01% 756
2025
Q4
$15.1K Sell
257
-3
-1% -$182 ﹤0.01% 463
2025
Q3
$14.5K Buy
260
+141
+118% +$7.55K ﹤0.01% 472
2025
Q2
$6.12K Buy
+119
New +$5.98K ﹤0.01% 721

Other funds holding TECH

Fortitude Family Office's TECH Position: Q2 2026 in Review

Fortitude Family Office reduced its Bio-Techne (TECH) stake by 44% in Q2 2026, selling an estimated $3.51K and leaving 82 shares worth $5.79K. The position accounts for ﹤0.01% of the portfolio, ranked #1012.

Fortitude Family Office first reported a position in TECH in Q2 2025 and has held it in 5 quarters since. The position peaked at $15.1K in Q4 2025. 597 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Fortitude Family Office held 82 shares of Bio-Techne worth $5.79K as of Q2 2026.
  • Fortitude Family Office sold 65 Bio-Techne shares in Q2 2026, an estimated $3.51K.
  • Bio-Techne made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1012 holding.
  • Fortitude Family Office first reported a position in Bio-Techne in Q2 2025 and has held it in 5 quarters since.
  • Fortitude Family Office's Bio-Techne position peaked at $15.1K in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.